ロボット制御による放射線治療市場 : 2028年までの世界予測

The global robotic radiotherapy market is projected to reach USD 1.9 billion by 2028 from USD 1.1 billion in 2023, growing at a CAGR of 11.9% during the forecast period.

世界のロボット制御による放射線治療市場は、2023年の11億米ドルから2028年までに19億米ドルに達すると予測されており、予測期間中に11.9%のCAGRで成長します。

The rising prevalence of cancer and the growing use of robotic radiotherapy is one of the major factors anticipated to boost market growth in the forecasting years.

“3D cameras (SGRT) segment of global robotic radiotherapy market to grow with the highest CAGR in the forecast period.”
On the basis of product, the robotic radiotherapy market is segmented into radiotherapy systems, software, 3D cameras, and others. The 3D cameras segment is expected to register the highest CAGR in the forecast period. Growth in this segment is majorly driven by the ability to offer non-invasive, real-time, 6-degree dimensional patient positioning and monitoring before and during the radiation therapy treatment process, resulting in accurate treatment delivery and wide acceptance by cancer facilities. However, factors such as significant maintenance costs associated with SGRT products, as well as the slow implementation of regulatory guidelines for robotic radiotherapy across emerging countries, are expected to restrain market growth.

“Lung cancer segment, by application, accounted for the largest market share of global robotic radiotherapy market in 2020.”
Based on application, the global robotic radiotherapy market is segmented into prostate cancer, breast cancer, lung cancer, head & neck cancer, colorectal cancer, and other cancers. The lung cancer segment accounted for the largest share of the global robotic radiotherapy market in 2022. The major drivers of this segment are increasing smoking rates, exposure to air pollutants, especially in urban areas with poor air quality, and exposure to carcinogens in mining, construction, and manufacturing. Modern lifestyles and dietary habits may further elevate the risk of lung cancer. As the global population ages, lung cancer incidence tends to rise, potentially leading to a higher number of cases.

“Increased installations and government initiatives to drive the segment growth of hospitals end-user segment.”
Based on the end user, the robotic radiotherapy market is segmented into hospitals and independent radiotherapy centers. Hospitals are the major end users of robotic radiotherapy products. The large share of this end-user segment is primarily attributed to the demand for automated radiation therapy systems, advancement in automated radiation therapy systems and the increasing installations of ART stations, and the rising government investments for effective ART and treatment.

“The APAC market, by region, to register highest growth rate in the forecast period.”
On the basis of region, the robotic radiotherapy market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. The Asia-Pacific market is likely witness significant growth owing to increase in disposable income and increase in cancer patient pool. Focus on governments on investment on robotic radiotherapy systems, modernization of industrial and public infrastructures, and rising penetration of cutting-edge radiation therapy in hospitals. However, a dearth of skilled professionals for the operation of advanced instruments, slow implementation of therapy due to budgetary constraints, and pricing pressures faced by prominent product manufacturers are the key factors restraining the growth of the robotic radiotherapy market despite the great opportunities available in the APAC region.

A breakdown of the primary participants referred to for this report is provided below:
• By Company Type: Tier 1–48%, Tier 2–36%, and Tier 3– 16%
• By Designation: C-level–10%, Director-level–14%, and Others–76%
• By Region: North America–40%, Europe–32%, Asia Pacific–20%, Latin America–5%, MEA- 3%

The prominent players in the robotic radiotherapy market are Siemens Healthcare GmbH (Germany), Elekta (Sweden), Accuray Incorporated (US), IBA (Belgium), ViewRay Technologies, Inc. (US), C-RAD (Sweden), IBA Worldwide (Belgium), Hitachi Ltd. (Japan (US), Mevion Medical Systems (US), Optivus Proton Therapy, Inc. (US) and Panacea Medical Technologies Pvt. Ltd. (India), among others.

Research Coverage
This report studies the robotic radiotherapy market based on product, technology, application, end-user, and region. It also covers the factors affecting market growth, analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to four main regions (and the respective countries in these regions).
Reasons to Buy the Report
The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their market presence.

This report provides insights on the following pointers:
• Analysis of key drivers (growing demand for non-invasive treatments, technological advancements, rising prevalence of cancer, growing use of automated radiation therapy for cancer treatment), restraints (lack of adequate healthcare, high cost of automated radiation therapy systems, complex nature of technology, dearth of skilled radiologist), opportunities (rising healthcare expenditure across developing countries, growing government and private investments, adoption of radiation therapy), and challenges (risk of radiation exposure, competition from alternative treatment modalities) influencing the growth of robotic radiotherapy market
• Market Penetration: Comprehensive information on the product portfolios offered by the top players in the robotic radiotherapy market
• Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the robotic radiotherapy market
• Market Development: Comprehensive information on lucrative emerging regions
• Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the market
• Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.

Table of Contents

1            INTRODUCTION            22

1.1         STUDY OBJECTIVES      22

1.2         MARKET DEFINITION   22

1.2.1      INCLUSIONS AND EXCLUSIONS 22

1.3         MARKET SCOPE             23

1.3.1      MARKETS COVERED     23

1.3.2      GEOGRAPHIES COVERED          23

1.3.3      YEARS CONSIDERED     24

1.3.4      CURRENCY CONSIDERED          24

1.4         LIMITATIONS   24

1.5         MARKET STAKEHOLDERS          25

1.5.1      RECESSION IMPACT      25

2            RESEARCH METHODOLOGY     26

2.1         RESEARCH DATA           26

2.2         RESEARCH DESIGN       27

2.2.1      SECONDARY RESEARCH             27

2.2.2      PRIMARY RESEARCH     29

2.2.2.1   Primary sources   29

2.2.2.2   Key data from secondary sources     30

2.2.2.3   Breakdown of primaries     30

FIGURE 1           BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 30

FIGURE 2           BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION    31

2.3         MARKET SIZE ESTIMATION       31

FIGURE 3           RESEARCH METHODOLOGY: HYPOTHESIS BUILDING  32

2.3.1      BOTTOM-UP APPROACH           32

2.3.1.1   Approach 1: Company revenue estimation approach    33

FIGURE 4           MARKET SIZE ESTIMATION FOR ROBOTIC RADIOTHERAPY: APPROACH 1 (COMPANY REVENUE ESTIMATION)         33

2.3.1.2   Approach 2: Customer-based market estimation          33

FIGURE 5           ROBOTIC RADIOTHERAPY MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH           34

2.3.1.3   Approach 3: Top-down approach    34

2.3.1.4   Approach 4: Primary interviews       34

2.3.2      TOP-DOWN APPROACH             35

2.4         DATA VALIDATION APPROACH             37

FIGURE 6           DATA TRIANGULATION METHODOLOGY         37

2.5         MARKET SHARE ASSESSMENT   38

2.6         STUDY ASSUMPTIONS  38

2.7         RISK ASSESSMENT         38

TABLE 1             LIMITATIONS AND ASSOCIATED RISKS 38

2.8         GROWTH RATE ASSUMPTIONS 38

2.9         RECESSION IMPACT ANALYSIS 39

3            EXECUTIVE SUMMARY 40

FIGURE 7           ROBOTIC RADIOTHERAPY MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION)     40

FIGURE 8          ROBOTIC RADIOTHERAPY MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)     41

FIGURE 9           ROBOTIC RADIOTHERAPY MARKET, BY TECHNOLOGY, 2023 VS. 2028 (USD MILLION)             41

FIGURE 10         ROBOTIC RADIOTHERAPY MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)     42

FIGURE 11         GEOGRAPHICAL SNAPSHOT: ROBOTIC RADIOTHERAPY MARKET            43

4            PREMIUM INSIGHTS      44

4.1         ROBOTIC RADIOTHERAPY MARKET OVERVIEW             44

FIGURE 12         INCREASING GERIATRIC POPULATION AND GROWING R&D INVESTMENTS TO DRIVE MARKET        44

4.2         ROBOTIC RADIOTHERAPY MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION)          45

FIGURE 13         RADIOTHERAPY SYSTEMS TO DOMINATE MARKET IN 2028              45

4.3         NORTH AMERICA: ROBOTIC RADIOTHERAPY MARKET, BY COUNTRY AND END USER, 2022 (USD MILLION)    45

FIGURE 14         HOSPITALS DOMINATED END-USER MARKET IN 2022   45

4.4         ROBOTIC RADIOTHERAPY MARKET: COMPARISON OF COUNTRY-WISE GROWTH RATES  46

FIGURE 15         INDIA AND CHINA TO SHOW HIGHEST GROWTH DURING FORECAST PERIOD       46

5            MARKET OVERVIEW     47

5.1         INTRODUCTION            47

5.2         MARKET DYNAMICS     47

FIGURE 16         ROBOTIC RADIOTHERAPY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES    47

5.2.1      DRIVERS            48

5.2.1.1   Rising prevalence of cancer 48

TABLE 2             PROJECTED INCREASE IN CANCER CASES, 2020–2040     48

5.2.1.2   Growing demand for noninvasive treatment  48

5.2.2      RESTRAINTS     49

5.2.2.1   Premium Product Pricing  49

5.2.2.2   Complexities associated with automated/robotic radiotherapy   49

5.2.3      OPPORTUNITIES           50

5.2.3.1   Rising healthcare expenditure across emerging economies         50

5.2.3.2   Government and private investments to boost cancer treatment availability              50

5.2.4      CHALLENGES   51

5.2.4.1   Risk of radiation exposure  51

5.2.4.2   Dearth of skilled personnel 51

5.3         TECHNOLOGY ANALYSIS           52

5.4         PORTER’S FIVE FORCES ANALYSIS         52

TABLE 3             ROBOTIC RADIOTHERAPY MARKET: PORTER’S FIVE FORCES ANALYSIS          52

5.4.1      THREAT OF NEW ENTRANTS    52

5.4.2      THREAT OF SUBSTITUTES         53

5.4.3      BARGAINING POWER OF SUPPLIERS     53

5.4.4      BARGAINING POWER OF BUYERS           53

5.4.5      INTENSITY OF COMPETITIVE RIVALRY 53

5.5         KEY STAKEHOLDERS AND BUYING CRITERIA    53

5.5.1      KEY STAKEHOLDERS IN BUYING PROCESS         53

FIGURE 17         INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF RADIOTHERAPY SYSTEMS         53

TABLE 4             INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR KEY PRODUCT SEGMENTS (%) 54

5.6         REGULATORY ANALYSIS            54

5.6.1      US         54

TABLE 5             US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS              55

5.6.2      EUROPE             55

5.6.3      JAPAN  55

TABLE 6             JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA              56

5.7         REIMBURSEMENT SCENARIO    56

TABLE 7             CPT CODES FOR IMRT  56

TABLE 8             CPT CODES FOR SBRT  57

TABLE 9             CPT CODES FOR PROTON BEAM THERAPY        57

TABLE 10           FREESTANDING PER COURSE NATIONAL AVERAGE MEDICARE REIMBURSEMENT, 2021 VS 2022 58

TABLE 11           PROPOSED AMBULATORY PAYMENT CLASSIFICATION 2023 RATES  58

TABLE 12           IMPACT OF CLINICAL LABOR PRICE CHANGES ON RADIATION ONCOLOGY SERVICES  59

5.8         ECOSYSTEM ANALYSIS 59

5.9         VALUE CHAIN ANALYSIS            60

5.9.1      RESEARCH & DEVELOPMENT   60

5.9.2      PROCUREMENT AND PRODUCT DEVELOPMENT           60

5.9.3      MARKETING, SALES & DISTRIBUTION, AND POST-SALES SERVICES              60

FIGURE 18         VALUE CHAIN ANALYSIS IN ROBOTIC RADIOTHERAPY MARKET            61

5.10       SUPPLY CHAIN ANALYSIS          62

5.10.1    PROMINENT COMPANIES          62

5.10.2    SMALL & MEDIUM-SIZED COMPANIES  62

5.10.3    END USERS       62

FIGURE 19         SUPPLY CHAIN ANALYSIS OF ROBOTIC RADIOTHERAPY MARKET            62

5.11       PRICING ANALYSIS        63

TABLE 13           PRICING ANALYSIS OF RADIOTHERAPY SYSTEMS (USD)              63

5.12       PATENT ANALYSIS        64

FIGURE 20         TOP TEN PATENT APPLICANTS FOR RADIOTHERAPY (JANUARY 2012 TO JUNE 2022)  64

FIGURE 21         TOP TEN PATENT INVENTORS FOR RADIOTHERAPY (JANUARY 2012 TO JUNE 2023)  64

FIGURE 22         TOP TEN PATENT OWNERS FOR RADIOTHERAPY (JANUARY 2012 TO JUNE 2023)       65

5.13       TRADE ANALYSIS          65

TABLE 14           IMPORT DATA FOR RADIOTHERAPY SYSTEMS (HS CODE 9022), BY COUNTRY, 2018–2022 (USD THOUSAND)       65

TABLE 15           EXPORT DATA FOR RADIOTHERAPY SYSTEMS (HS CODE 9022), BY COUNTRY, 2018–2022 (USD THOUSAND)       66

5.14       KEY CONFERENCES AND EVENTS IN 2022–2023 67

TABLE 16           ROBOTIC RADIOTHERAPY MARKET: DETAILED LIST OF KEY CONFERENCES AND EVENTS IN 2022–2023         67

5.15       TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 68

FIGURE 23         EMERGING TRENDS AND OPPORTUNITIES AFFECTING FUTURE REVENUE MIX 68

6            ROBOTIC RADIOTHERAPY MARKET, BY PRODUCT        69

6.1         INTRODUCTION            70

TABLE 17           ROBOTIC RADIOTHERAPY MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 70

6.2         RADIOTHERAPY SYSTEMS         70

6.2.1      RISING USE OF AI AND AUTOMATION TO DRIVE MARKET         70

TABLE 18           RADIOTHERAPY SYSTEMS MARKET, BY REGION, 2020–2028 (USD MILLION) 71

6.3         SOFTWARE       71

6.3.1      NEED TO ENSURE TREATMENT EFFECTIVENESS AND ACCURACY TO BOOST GROWTH           71

TABLE 19           SOFTWARE MARKET, BY REGION, 2020–2028 (USD MILLION)              72

6.4         3D CAMERAS    72

6.4.1      GROWING USE OF SGRT TO DRIVE DEMAND    72

TABLE 20           3D CAMERAS MARKET, BY REGION, 2020–2028 (USD MILLION)              72

6.5         OTHER PRODUCTS       73

TABLE 21           OTHER ROBOTIC RADIOTHERAPY MARKET, BY REGION, 2020–2028 (USD MILLION)     73

7            ROBOTIC RADIOTHERAPY MARKET, BY TECHNOLOGY 74

7.1         INTRODUCTION            75

TABLE 22           ROBOTIC RADIOTHERAPY MARKET, BY TECHNOLOGY, 2020–2028 (USD MILLION)     75

7.2         LINEAR ACCELERATORS            75

TABLE 23           LINEAR ACCELERATORS MARKET, BY TYPE, 2020–2028 (USD MILLION)          75

7.2.1      CONVENTIONAL LINEAR ACCELERATORS         76

7.2.1.1   Longer treatment duration to limit adoption  76

7.2.2      MRI LINEAR ACCELERATORS    76

7.2.2.1   Rising awareness about benefits to enhance demand    76

7.3         STEREOTACTIC RADIATION THERAPY 76

TABLE 24           STEREOTACTIC RADIATION THERAPY MARKET, BY TYPE, 2020–2028 (USD MILLION)          77

7.3.1      CYBERKNIFE     77

7.3.1.1   Precision and correction capabilities to boost adoption 77

7.3.2      GAMMA KNIFE 77

7.3.2.1   Ongoing product development to drive market            77

7.4         PARTICLE THERAPY SYSTEMS  78

TABLE 25           PARTICLE THERAPY SYSTEMS MARKET, BY TYPE, 2020–2028 (USD MILLION) 78

7.4.1      PROTON BEAM THERAPY          78

7.4.1.1   Rising establishment of proton therapy cancer centers to drive market     78

7.4.2      HEAVY ION THERAPY   79

7.4.2.1   Limited number of facilities to slow growth    79

8            ROBOTIC RADIOTHERAPY MARKET, BY APPLICATION 80

8.1         INTRODUCTION            81

TABLE 26           ROBOTIC RADIOTHERAPY MARKET, BY APPLICATION, 2020–2028 (USD MILLION)     81

8.2         LUNG CANCER 81

8.2.1      LUNG CANCER TO DOMINATE APPLICATIONS MARKET            81

TABLE 27           ROBOTIC RADIOTHERAPY MARKET FOR LUNG CANCER, BY REGION, 2020–2028 (USD MILLION)       82

8.3         BREAST CANCER            82

8.3.1      INCREASING INCIDENCE OF BREAST CANCER TO DRIVE MARKET              82

TABLE 28           ROBOTIC RADIOTHERAPY MARKET FOR BREAST CANCER, BY REGION, 2020–2028 (USD MILLION)       82

8.4         PROSTATE CANCER      83

8.4.1      PREFERENCE FOR NONINVASIVE TREATMENT TO BOOST GROWTH              83

TABLE 29           ROBOTIC RADIOTHERAPY MARKET FOR PROSTATE CANCER, BY REGION, 2020–2028 (USD MILLION)  83

8.5         HEAD & NECK CANCER 83

8.5.1      GROWING UTILIZATION OF CYBERKNIFE FOR TREATMENT TO DRIVE MARKET            83

TABLE 30           ROBOTIC RADIOTHERAPY MARKET FOR HEAD & NECK CANCER, BY REGION, 2020–2028 (USD MILLION)             84

8.6         COLORECTAL CANCER 84

8.6.1      RISING INCIDENCE OF COLORECTAL CANCER TO SUPPORT GROWTH              84

TABLE 31           ROBOTIC RADIOTHERAPY MARKET FOR COLORECTAL CANCER, BY REGION, 2020–2028 (USD MILLION)             85

8.7         OTHER CANCERS           85

TABLE 32           ROBOTIC RADIOTHERAPY MARKET FOR OTHER CANCERS, BY REGION, 2020–2028 (USD MILLION)       85

9            ROBOTIC RADIOTHERAPY MARKET, BY END USER        86

9.1         INTRODUCTION            87

TABLE 33           ROBOTIC RADIOTHERAPY MARKET, BY END USER, 2020–2028 (USD MILLION) 87

9.2         HOSPITALS       87

9.2.1      LARGE NUMBER OF SURGICAL AND DIAGNOSTIC PROCEDURES TO PROPEL MARKET          87

TABLE 34           ROBOTIC RADIOTHERAPY MARKET FOR HOSPITALS, BY REGION, 2020–2028 (USD MILLION)       88

9.3         INDEPENDENT RADIOTHERAPY CENTERS        88

9.3.1      LIMITED SURGICAL CAPABILITIES OF AVAILABLE PRODUCTS TO RESTRAIN ADOPTION  88

TABLE 35           ROBOTIC RADIOTHERAPY MARKET FOR INDEPENDENT RADIOTHERAPY CENTERS, BY REGION, 2020–2028 (USD MILLION)         88

10          ROBOTIC RADIOTHERAPY MARKET, BY REGION            89

10.1       INTRODUCTION            90

TABLE 36           ROBOTIC RADIOTHERAPY MARKET, BY REGION, 2020–2028 (USD MILLION) 90

10.2       NORTH AMERICA          90

10.2.1    NORTH AMERICA: RECESSION IMPACT 90

FIGURE 24         NORTH AMERICA: ROBOTIC RADIOTHERAPY MARKET SNAPSHOT        91

TABLE 37           NORTH AMERICA: ROBOTIC RADIOTHERAPY MARKET, BY COUNTRY, 2020–2028 (USD MILLION)    92

TABLE 38           NORTH AMERICA: ROBOTIC RADIOTHERAPY MARKET, BY PRODUCT, 2020–2028 (USD MILLION)   92

TABLE 39           NORTH AMERICA: ROBOTIC RADIOTHERAPY MARKET, BY TECHNOLOGY, 2020–2028 (USD MILLION)          92

TABLE 40           NORTH AMERICA: ROBOTIC RADIOTHERAPY MARKET, BY APPLICATION, 2020–2028 (USD MILLION)           93

TABLE 41           NORTH AMERICA: ROBOTIC RADIOTHERAPY MARKET, BY END USER, 2020–2028 (USD MILLION)    93

10.2.2    US         93

10.2.2.1 US to dominate North American market over forecast period     93

TABLE 42           US: ROBOTIC RADIOTHERAPY MARKET, BY PRODUCT, 2020–2028 (USD MILLION)     94

10.2.3    CANADA            94

10.2.3.1 Increasing government initiatives and favorable reimbursement to drive market              94

TABLE 43           CANADA: ROBOTIC RADIOTHERAPY MARKET, BY PRODUCT, 2020–2028 (USD MILLION)          94

10.3       EUROPE             95

10.3.1    EUROPE: RECESSION IMPACT   95

TABLE 44           EUROPE: ROBOTIC RADIOTHERAPY MARKET, BY COUNTRY, 2020–2028 (USD MILLION)          95

TABLE 45           EUROPE: ROBOTIC RADIOTHERAPY MARKET, BY PRODUCT, 2020–2028 (USD MILLION)          96

TABLE 46           EUROPE: ROBOTIC RADIOTHERAPY MARKET, BY TECHNOLOGY, 2020–2028 (USD MILLION)          96

TABLE 47           EUROPE: ROBOTIC RADIOTHERAPY MARKET, BY APPLICATION, 2020–2028 (USD MILLION)           97

TABLE 48           EUROPE: ROBOTIC RADIOTHERAPY MARKET, BY END USER, 2020–2028 (USD MILLION)          97

10.3.2    GERMANY         97

10.3.2.1 Increasing aging population and rising life expectancy to drive market     97

TABLE 49           GERMANY: ROBOTIC RADIOTHERAPY MARKET, BY PRODUCT, 2020–2028 (USD MILLION)          98

10.3.3    FRANCE             98

10.3.3.1 Well-developed healthcare sector and rising geriatric population to drive market              98

TABLE 50           FRANCE: ROBOTIC RADIOTHERAPY MARKET, BY PRODUCT, 2020–2028 (USD MILLION)          98

10.3.4    UK         99

10.3.4.1 High burden of chronic diseases to support adoption   99

TABLE 51           UK: ROBOTIC RADIOTHERAPY MARKET, BY PRODUCT, 2020–2028 (USD MILLION)     99

10.3.5    ITALY   99

10.3.5.1 Increasing geriatric population to drive market            99

TABLE 52           ITALY: ROBOTIC RADIOTHERAPY MARKET, BY PRODUCT, 2020–2028 (USD MILLION)          99

10.3.6    SPAIN   100

10.3.6.1 Technological developments in healthcare to drive market         100

TABLE 53           SPAIN: ROBOTIC RADIOTHERAPY MARKET, BY PRODUCT, 2020–2028 (USD MILLION)          100

10.3.7    REST OF EUROPE           100

TABLE 54           REST OF EUROPE: ROBOTIC RADIOTHERAPY MARKET, BY PRODUCT, 2020–2028 (USD MILLION)   101

10.4       ASIA PACIFIC    101

10.4.1    ASIA PACIFIC: RECESSION IMPACT        101

FIGURE 25         ASIA PACIFIC: ROBOTIC RADIOTHERAPY MARKET SNAPSHOT              102

TABLE 55           ASIA PACIFIC: ROBOTIC RADIOTHERAPY MARKET, BY COUNTRY, 2020–2028 (USD MILLION)    103

TABLE 56           ASIA PACIFIC: ROBOTIC RADIOTHERAPY MARKET, BY PRODUCT, 2020–2028 (USD MILLION)   103

TABLE 57           ASIA PACIFIC: ROBOTIC RADIOTHERAPY MARKET, BY TECHNOLOGY, 2020–2028 (USD MILLION)          104

TABLE 58           ASIA PACIFIC: ROBOTIC RADIOTHERAPY MARKET, BY APPLICATION, 2020–2028 (USD MILLION)           104

TABLE 59           ASIA PACIFIC: ROBOTIC RADIOTHERAPY MARKET, BY END USER, 2020–2028 (USD MILLION)             105

10.4.2    JAPAN  105

10.4.2.1 Rising geriatric population and surgical procedures to drive market         105

TABLE 60           JAPAN: ROBOTIC RADIOTHERAPY MARKET, BY PRODUCT, 2020–2028 (USD MILLION)          105

10.4.3    CHINA  106

10.4.3.1 Developing healthcare infrastructure to drive market   106

TABLE 61           CHINA: ROBOTIC RADIOTHERAPY MARKET, BY PRODUCT, 2020–2028 (USD MILLION)          106

10.4.4    INDIA   106

10.4.4.1 Rising awareness and government support to boost growth        106

TABLE 62           INDIA: ROBOTIC RADIOTHERAPY MARKET, BY PRODUCT, 2020–2028 (USD MILLION)          107

10.4.5    AUSTRALIA       107

10.4.5.1 Well-established healthcare system to favor adoption   107

TABLE 63           AUSTRALIA: ROBOTIC RADIOTHERAPY MARKET, BY PRODUCT, 2020–2028 (USD MILLION)   108

10.4.6    SOUTH KOREA 108

10.4.6.1 Growing target patient population to drive market       108

TABLE 64           SOUTH KOREA: ROBOTIC RADIOTHERAPY MARKET, BY PRODUCT, 2020–2028 (USD MILLION)   108

10.4.7    REST OF ASIA PACIFIC  109

TABLE 65           REST OF ASIA PACIFIC: ROBOTIC RADIOTHERAPY MARKET, BY PRODUCT, 2020–2028 (USD MILLION)   109

10.5       REST OF THE WORLD   109

10.5.1    REST OF THE WORLD: RECESSION IMPACT       109

TABLE 66           REST OF THE WORLD: ROBOTIC RADIOTHERAPY MARKET, BY PRODUCT, 2020–2028 (USD MILLION)   110

TABLE 67           REST OF THE WORLD: ROBOTIC RADIOTHERAPY MARKET, BY TECHNOLOGY, 2020–2028 (USD MILLION)          110

TABLE 68           REST OF THE WORLD: ROBOTIC RADIOTHERAPY MARKET, BY APPLICATION, 2020–2028 (USD MILLION)           111

TABLE 69           REST OF THE WORLD: ROBOTIC RADIOTHERAPY MARKET, BY END USER, 2020–2028 (USD MILLION)    111

11          COMPETITIVE LANDSCAPE       112

11.1       OVERVIEW        112

11.2       KEY PLAYER STRATEGIES          112

FIGURE 26         KEY DEVELOPMENTS IN ROBOTIC RADIOTHERAPY MARKET (2019 TO 2023)  113

11.3       REVENUE ANALYSIS      114

FIGURE 27         REVENUE ANALYSIS OF TOP FIVE PLAYERS (2019–2022) 114

11.4       MARKET SHARE ANALYSIS: ROBOTIC RADIOTHERAPY MARKET, BY KEY PLAYER (2022)        114

FIGURE 28         ROBOTIC RADIOTHERAPY MARKET SHARE, BY KEY PLAYER, 2022      114

TABLE 70           ROBOTIC RADIOTHERAPY MARKET: DEGREE OF COMPETITION 115

11.5       COMPANY EVALUATION MATRIX (2022)            116

11.5.1    STARS  116

11.5.2    PERVASIVE PLAYERS     116

11.5.3    EMERGING LEADERS    116

11.5.4    PARTICIPANTS 116

FIGURE 29         ROBOTIC RADIOTHERAPY MARKET: COMPANY EVALUATION MATRIX, 2022    117

11.6       COMPANY EVALUATION MATRIX FOR START-UPS/SMES (2022) 118

11.6.1    PROGRESSIVE COMPANIES       118

11.6.2    DYNAMIC COMPANIES 118

11.6.3    RESPONSIVE COMPANIES          118

11.6.4    STARTING BLOCKS       118

FIGURE 30         COMPANY EVALUATION MATRIX FOR START-UPS/SMES, 2022              119

11.7       COMPETITIVE BENCHMARKING            120

11.7.1    OVERALL COMPANY FOOTPRINT          120

TABLE 71           OVERALL FOOTPRINT ANALYSIS: ROBOTIC RADIOTHERAPY MARKET            120

11.7.2    COMPANY PRODUCT FOOTPRINT         121

TABLE 72           PRODUCT FOOTPRINT ANALYSIS: ROBOTIC RADIOTHERAPY MARKET            121

11.7.3    COMPANY REGIONAL FOOTPRINT        122

TABLE 73           REGIONAL FOOTPRINT ANALYSIS: ROBOTIC RADIOTHERAPY MARKET            122

11.8       COMPETITIVE SCENARIO (2019–2023)   123

11.8.1    PRODUCT LAUNCHES & APPROVALS    123

11.8.2    DEALS  123

11.8.3    OTHER DEVELOPMENTS           124

12          COMPANY PROFILES    125

12.1       KEY PLAYERS   125

(Business Overview, Products/Services/Solutions Offered, Recent Developments, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats)*

12.1.1    SIEMENS HEALTHINEERS AG (VARIAN MEDICAL SYSTEMS, INC.)              125

TABLE 74           SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW     125

FIGURE 31         SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT (2022)              126

12.1.2    ELEKTA             133

TABLE 75           ELEKTA: COMPANY OVERVIEW 133

FIGURE 32         ELEKTA: COMPANY SNAPSHOT (2022)  134

12.1.3    ACCURAY INCORPORATED       140

TABLE 76           ACCURAY INCORPORATED: COMPANY OVERVIEW        140

FIGURE 33         ACCURAY INCORPORATED: COMPANY SNAPSHOT (2022)              141

12.1.4    VIEWRAY TECHNOLOGIES, INC.             145

TABLE 77           VIEWRAY TECHNOLOGIES, INC.: COMPANY OVERVIEW 145

FIGURE 34         VIEWRAY TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2022)              146

12.1.5    C-RAD  150

TABLE 78           C-RAD: COMPANY OVERVIEW  150

FIGURE 35         C-RAD: COMPANY SNAPSHOT (2022)     151

12.1.6    IBA        153

TABLE 79           IBA: COMPANY OVERVIEW        153

FIGURE 36         IBA: COMPANY SNAPSHOT (2022)          154

12.1.7    HITACHI LTD.  157

TABLE 80           HITACHI LTD.: COMPANY OVERVIEW   157

FIGURE 37         HITACHI LTD.: COMPANY SNAPSHOT (2021)     158

12.1.8    MEVION MEDICAL SYSTEMS     160

TABLE 81           MEVION MEDICAL SYSTEMS: COMPANY OVERVIEW      160

12.1.9    PANACEA MEDICAL TECHNOLOGIES PVT. LTD.             163

TABLE 82           PANACEA MEDICAL TECHNOLOGIES PVT. LTD.: COMPANY OVERVIEW        163

12.1.10  P-CURE 164

TABLE 83           P-CURE: COMPANY OVERVIEW 164

12.1.11  PROVISION HEALTHCARE         165

TABLE 84           PROVISION HEALTHCARE: COMPANY OVERVIEW          165

12.1.12  SUMITOMO HEAVY INDUSTRY LTD.     166

TABLE 85           SUMITOMO HEAVY INDUSTRY LTD.: COMPANY OVERVIEW              166

FIGURE 38         SUMITOMO HEAVY INDUSTRIES: COMPANY SNAPSHOT (2021)              167

12.1.13  PHILIPS HEALTHCARE 169

TABLE 86           PHILIPS HEALTHCARE: COMPANY OVERVIEW  169

FIGURE 39         PHILIPS HEALTHCARE: COMPANY SNAPSHOT (2022)    170

12.1.14  RAYSEARCH LABORATORIES    172

TABLE 87           RAYSEARCH LABORATORIES: COMPANY OVERVIEW     172

FIGURE 40         RAYSEARCH LABORATORIES: COMPANY SNAPSHOT (2022)              173

12.1.15  PROTOM INTERNATIONAL, INC.            176

TABLE 88           PROTOM INTERNATIONAL, INC.: COMPANY OVERVIEW              176

12.1.16  OPTIVUS PROTON THERAPY, INC.         177

TABLE 89           OPTIVUS PROTON THERAPY, INC.: COMPANY OVERVIEW              177

12.1.17  TOSHIBA CORPORATION           178

TABLE 90           TOSHIBA CORPORATION: COMPANY OVERVIEW           178

FIGURE 41         TOSHIBA CORPORATION: COMPANY SNAPSHOT (2022)              179

12.1.18  VISION RT LTD.             181

TABLE 91           VISION RT LTD.: COMPANY OVERVIEW 181

12.1.19  ADVANCED ONCOTHERAPY PLC           183

TABLE 92           ADVANCED ONCOTHERAPY PLC: COMPANY OVERVIEW              183

12.1.20  MIM SOFTWARE INC.    184

TABLE 93           MIM SOFTWARE INC.: COMPANY OVERVIEW     184

*Business Overview, Products/Services/Solutions Offered, Recent Developments, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats might not be captured in case of unlisted companies.

12.2       OTHER PLAYERS           186

12.2.1    STANDARD IMAGING, INC.        186

12.2.2    BRAINLAB AG   186

12.2.3    MAGNETTX ONCOLOGY SOLUTIONS LTD.        187

12.2.4    PTW FREIBURG GMBH  187

12.2.5    DOSISOFT SA    188

13          APPENDIX         189

13.1       DISCUSSION GUIDE      189

13.2       KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL             194

13.3       CUSTOMIZATION OPTIONS      196

13.4       RELATED REPORTS       197

13.5       AUTHOR DETAILS         198

MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。

※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。

ライセンス別価格表

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

ライセンスタイプ1

ライセンスタイプ2

ライセンスタイプ3

ライセンスタイプ4

ミニレポート　※定性調査にフォーカスした調査レポートです。詳細はお問合せください。

ご購入に関するご案内

価格・納期について

• 価格
  • ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス
    • 1名のみレポートファイルのご利用が可能です。
  • マルチユーザライセンス
    • 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
  • コーポレートライセンス
    • 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
  • エンタープライズサイトライセンス
    • 特別ライセンスです。適用範囲についてはお問合せください。
• 納品形態
  • Eメール
• 納期
  • 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。

最新調査レポート

• データセンターUPS市場規模、シェア、動向、2030年までの世界予測 2025-10-31
• 高純度ガス市場規模、シェア、動向、2030年までの世界予測 2025-10-30
• 動物用生物学的製剤市場規模、シェア、動向、2030年までの世界予測 2025-10-30
• エンジニアリング樹脂向け難燃剤市場規模、シェア、動向、2030年までの世界予測 2025-10-29
• アプリケーションモダナイゼーションサービス市場規模、シェア、動向、2031年までの世界予測 2025-10-29

MarketsandMarkets  出版レポート一覧